FOLD logo

Amicus Therapeutics (FOLD) Working capital

annual working capital:

$356.03M+$40.66M(+12.89%)
December 31, 2024

Summary

  • As of today (May 25, 2025), FOLD annual working capital is $356.03 million, with the most recent change of +$40.66 million (+12.89%) on December 31, 2024.
  • During the last 3 years, FOLD annual working capital has fallen by -$94.83 million (-21.03%).
  • FOLD annual working capital is now -23.43% below its all-time high of $464.97 million, reached on December 31, 2018.

Performance

FOLD Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

quarterly working capital:

$357.91M+$1.88M(+0.53%)
March 31, 2025

Summary

  • As of today (May 25, 2025), FOLD quarterly working capital is $357.91 million, with the most recent change of +$1.88 million (+0.53%) on March 31, 2025.
  • Over the past year, FOLD quarterly working capital has increased by +$68.77 million (+23.79%).
  • FOLD quarterly working capital is now -34.37% below its all-time high of $545.33 million, reached on June 30, 2019.

Performance

FOLD quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

FOLD Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.9%+23.8%
3 y3 years-21.0%-8.0%
5 y5 years-9.0%+13.2%

FOLD Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-21.0%+25.0%-8.0%+37.0%
5 y5-year-21.0%+25.0%-32.4%+37.0%
alltimeall time-23.4%+1499.0%-34.4%+1507.4%

FOLD Working capital History

DateAnnualQuarterly
Mar 2025
-
$357.91M(+0.5%)
Dec 2024
$356.03M(+12.9%)
$356.03M(+4.6%)
Sep 2024
-
$340.34M(+15.9%)
Jun 2024
-
$293.63M(+1.6%)
Mar 2024
-
$289.14M(-8.3%)
Dec 2023
$315.37M(+10.7%)
$315.37M(+7.3%)
Sep 2023
-
$293.80M(+7.4%)
Jun 2023
-
$273.59M(+4.7%)
Mar 2023
-
$261.31M(-8.2%)
Dec 2022
$284.80M(-36.8%)
$284.80M(-3.1%)
Sep 2022
-
$293.89M(-11.7%)
Jun 2022
-
$333.02M(-14.4%)
Mar 2022
-
$389.20M(-13.7%)
Dec 2021
$450.86M(+0.2%)
$450.86M(-14.8%)
Sep 2021
-
$529.44M(+43.7%)
Jun 2021
-
$368.51M(-8.6%)
Mar 2021
-
$403.24M(-10.4%)
Dec 2020
$449.79M(+15.0%)
$449.79M(-5.0%)
Sep 2020
-
$473.55M(+71.8%)
Jun 2020
-
$275.58M(-12.9%)
Mar 2020
-
$316.24M(-19.2%)
Dec 2019
$391.26M(-15.9%)
$391.26M(-19.1%)
Sep 2019
-
$483.58M(-11.3%)
Jun 2019
-
$545.33M(+30.7%)
Mar 2019
-
$417.18M(-10.3%)
Dec 2018
$464.97M(+44.4%)
$464.97M(-13.1%)
Sep 2018
-
$535.15M(+2.3%)
Jun 2018
-
$523.27M(+15.9%)
Mar 2018
-
$451.33M(+40.2%)
Dec 2017
$321.93M(+40.5%)
$321.93M(-11.3%)
Sep 2017
-
$362.85M(+158.6%)
Jun 2017
-
$140.31M(-24.8%)
Mar 2017
-
$186.61M(-18.5%)
Dec 2016
$229.10M(+60.2%)
$229.10M(+68.3%)
Sep 2016
-
$136.10M(-0.8%)
Jun 2016
-
$137.22M(+31.8%)
Mar 2016
-
$104.09M(-27.2%)
DateAnnualQuarterly
Dec 2015
$142.99M(+6.4%)
$142.99M(-30.0%)
Sep 2015
-
$204.19M(-41.3%)
Jun 2015
-
$348.10M(+167.3%)
Mar 2015
-
$130.23M(-3.1%)
Dec 2014
$134.39M(+72.7%)
$134.39M(+83.1%)
Sep 2014
-
$73.41M(+7.6%)
Jun 2014
-
$68.25M(+6.5%)
Mar 2014
-
$64.08M(-17.6%)
Dec 2013
$77.82M(-18.4%)
$77.82M(+39.7%)
Sep 2013
-
$55.71M(-17.1%)
Jun 2013
-
$67.21M(-15.8%)
Mar 2013
-
$79.82M(-16.3%)
Dec 2012
$95.37M(+101.2%)
$95.37M(-7.0%)
Sep 2012
-
$102.55M(+16.7%)
Jun 2012
-
$87.86M(-9.9%)
Mar 2012
-
$97.52M(+105.8%)
Dec 2011
$47.39M(-49.3%)
$47.39M(-18.0%)
Sep 2011
-
$57.77M(-18.9%)
Jun 2011
-
$71.22M(-14.6%)
Mar 2011
-
$83.41M(-10.8%)
Dec 2010
$93.46M(+34.9%)
$93.46M(+78.6%)
Sep 2010
-
$52.33M(-18.2%)
Jun 2010
-
$64.00M(-14.8%)
Mar 2010
-
$75.10M(+8.4%)
Dec 2009
$69.29M(-37.1%)
$69.29M(-9.4%)
Sep 2009
-
$76.49M(-12.9%)
Jun 2009
-
$87.85M(-10.8%)
Mar 2009
-
$98.48M(-10.6%)
Dec 2008
$110.21M(-25.2%)
$110.21M(-10.6%)
Sep 2008
-
$123.31M(-6.1%)
Jun 2008
-
$131.32M(-6.7%)
Mar 2008
-
$140.82M(-4.4%)
Dec 2007
$147.25M(+228.6%)
$147.25M(+32.6%)
Sep 2007
-
$111.08M(-7.6%)
Jun 2007
-
$120.19M(+101.9%)
Mar 2007
-
$59.53M(+32.8%)
Dec 2006
$44.81M(+101.3%)
$44.81M(+101.3%)
Dec 2005
$22.27M
$22.27M

FAQ

  • What is Amicus Therapeutics annual working capital?
  • What is the all time high annual working capital for Amicus Therapeutics?
  • What is Amicus Therapeutics annual working capital year-on-year change?
  • What is Amicus Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly working capital year-on-year change?

What is Amicus Therapeutics annual working capital?

The current annual working capital of FOLD is $356.03M

What is the all time high annual working capital for Amicus Therapeutics?

Amicus Therapeutics all-time high annual working capital is $464.97M

What is Amicus Therapeutics annual working capital year-on-year change?

Over the past year, FOLD annual working capital has changed by +$40.66M (+12.89%)

What is Amicus Therapeutics quarterly working capital?

The current quarterly working capital of FOLD is $357.91M

What is the all time high quarterly working capital for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly working capital is $545.33M

What is Amicus Therapeutics quarterly working capital year-on-year change?

Over the past year, FOLD quarterly working capital has changed by +$68.77M (+23.79%)
On this page